Developed by Canadian researchers from Laval University and CHU de Québec, Spinalon is an oral pill composed of three active molecules capable together of triggering short bouts of locomotor-like activity in the legs of spinal cord injured patients who had been chronically paralyzed for years.
“It does not restore normal operation. An individual can not turn right, left or have 45 minutes to get groceries. It’s not the goal. This is to allow an intense treadmill training […] to counter all the secondary health problems of these people, “says researcher Pierre Guertin.